SCHEMBL7653103

SCHEMBL7653103

O=S(=O)(Cl)c1ccc(Oc2ccc(-c3ncccn3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 1/20 0.50
LMNA P02545 6/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP3A4 P08684 1/20 0.43
HTT P42858 6/20 0.41
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
SOS1 Q07889 1/20 0.41
BCL2L1 Q07817 1/20 0.39
MCL1 Q07820 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.38
TSHR P16473 2/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
XBP1 P17861 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
MDM2 Q00987 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL998552 0.89 CYP3A4 (0.50) CLK4LMNAKDM4ECYP3A4ALDH1A1
Hydrochloric Acid SCHEMBL7653109 0.83 CLK4 (0.47) CLK4LMNAKDM4ECYP3A4HTT
SCHEMBL433497 0.81 HTT (0.58) LMNAHTTALDH1A1HSD17B10TDP1
SCHEMBL9720036 0.81 HTT (0.58) LMNAHTTALDH1A1HSD17B10TDP1
SCHEMBL9539212 0.80 ALDH1A1 (0.56) LMNAKDM4EHTTALDH1A1HSD17B10
SCHEMBL7892614 0.80 SOS1 (0.58) LMNAKDM4EHTTALDH1A1HSD17B10
SCHEMBL7657519 0.79 HTT (0.44) LMNAKDM4ECYP3A4HTTALDH1A1
SCHEMBL31244 0.77 SOS1 (0.64) LMNAKDM4EHTTALDH1A1HSD17B10
SCHEMBL9536733 0.77 SOS1 (0.64) LMNAKDM4EHTTALDH1A1HSD17B10
SCHEMBL7014701 0.77 CLK4 (0.61) CLK4ALDH1A1TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6339092-B1 FOR THERAPY RHEUMATOID ARTHRITIS, ARTHROSIS, TUMOUR INVASION AND GROWTH, INCLUDING MALIGNANT SPREAD AND THE FORMATION OF METASTASES, ULCERATIONS, ATHEROSCLEROSIS ADIR ET COMPAGNIE (FR) 2002-01-15 US disclosed